ISA-101 (ISA Pharmaceuticals)

N/A

Report date: 2025/01/26 15:42:18

Base Information

Drug NameISA-101 (ISA Pharmaceuticals)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIsa Pharmaceuticals Bv

China Registration ClassN/A

Develop Information

Active CompaniesIsa Pharmaceuticals Bv

Inactive CompaniesN/A

Active IndicationsUterine Cervical Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A